Task: Answer the multiple-choice question.
Question: Which drug exhibits a 7.078% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a CCc1ccc(N2CC(C(=O)NCCC3=CCCCC3)CC2=O)cc1
b COc1ccccc1CN1CC(C(=O)NCCc2cn[nH]c2)CCC1=O
c O=C(COC(=O)c1cc(=O)[nH]c2ccccc12)Nc1nccs1
d NC(=O)c1ccccc1SCC(=O)NCc1ccco1
Answer: a. CCc1ccc(N2CC(C(=O)NCCC3=CCCCC3)CC2=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCc1ccc(N2CC(C(=O)NCCC3=CCCCC3)CC2=O)cc1
CCc1ccc(N2CC(C(=O)NCCC3=CCCCC3)CC2=O)cc1
N-[2-(cyclohexen-1-yl)ethyl]-1-(4-ethylphenyl)-5-oxopyrrolidine-3-carboxamide